Pfizer (PFE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled ‘A Phase 2b/3, ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Pfizer (PFE) offers potential 20-30% upside despite revenue risks. Explore its valuation, pipeline prospects, and dividend ...

The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.

One Louisiana woman, Robin Phillip, said she developed an intracranial meningioma that caused her to lose vision in her left ...

Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 19, Pfizer Inc. (NYSE:PFE ...

Pfizer's stock has been trading at low levels for a while. Diminished growth and concerns about the future have investors ...

President Donald Trump’s new partnership with Pfizer to sell drugs directly to consumers is being cast as a major ...

Pfizer faces lawsuits from 1,000 women alleging Depo-Provera birth control caused brain tumours, amid new research showing ...

Pfizer is working hard to deal with some big headwinds it has coming up, but in five years, this should all be in the past.